HOOK

HOOKIPA Pharma Inc.

OTCHealthcareBiotechnologyUS

USD1.15

+0.00 (+0.00%)

Rating:B

Company Profile

CEO

Malte Peters

IPO Date

2019-04-18

Sector

Healthcare

Industry

Biotechnology

Exchange

OTC

Country

Market Metrics

Open

$1.15

Prev. Close

$1.15

Day Low

$1.15

Day High

$1.15

52W Low

$0.81

52W High

$1.55

Market Cap

$0.01B

News SentimentBullish

Articles

Avg Positive

44.3%

Avg Negative

12.3%

Avg Neutral

43.7%

News Feed

Hookipa Pharma's Cancer Immunotherapy Shows T-Cell Response, Interim Efficacy in Pretreated HPV16+ Cancer Settings

Benzinga·6/8/2021·↑ positive

HOOKIPA Phase 1 HB-200 data show unprecedented T cell response, favorable tolerability, and preliminary efficacy as monotherapy for advanced HPV16+ cancers

GlobeNewsWire·6/7/2021·↑ positive

HOOKIPA Pharma Inc. (HOOK) Soars 7.9%: Is Further Upside Left in the Stock?